Metaphase

Testicular Cancer - Global Pipeline Insights, 2022: Featuring Sanofi, Seagen, BioNTech, Context Therapeutics & Leadartis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Consumer, Health, Men, Clinical Trials, Oncology, Physical examination, Testicular cancer, News, Prednisone, Ageing, Tubulin, Survival rate, Prognosis, Route, Prostate cancer, Sanofi, European Medicines Agency, Complex, Microtubule, Cell cycle, II, Administration, BioNTech, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Cryptorchidism, Discovery, Epidemiology, Interphase, FDA, Cancer, SE, Knowledge, Carlos Roa, CLDN6, Route of administration, CAR, Risk, Metaphase, History, Food, Apoptosis, Therapy, Patient, RNA, Cabazitaxel, Clinical trial, EMA, Docetaxel, Dietary supplement, Vaccine, Pharmaceutical industry, Testicle

This "Testicular Cancer - Pipeline Insight, 2022" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Testicular Cancer pipeline landscape.

Key Points: 
  • This "Testicular Cancer - Pipeline Insight, 2022" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Testicular Cancer pipeline landscape.
  • Testicular cancer is one of the most common malignancies in men aged 15 to 45 years.
  • Complex environmental and genetic factors are involved in the development of testicular cancer; common risk factors include cryptorchidism, family history of testicular cancer, personal history of testicular cancer in the contralateral testis, age, and ethnicity.
  • Testicular Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

Metaphase Technologies Launches Configurable Catalog of LED Illuminators Built by CADENAS PARTsolutions

Retrieved on: 
Thursday, August 11, 2022
LED, Metaphase, Solution, CAD, PDF, Adobe Acrobat, OEM, 3D, Review, Technology, Organization, Telescopic sight, 3D printing, BRISTOL

CINCINNATI and BRISTOL, Pa., Aug. 11, 2022 /PRNewswire/ -- Metaphase Technologies, a nearly 30-year-old, Pennsylvania-based manufacturer of LED illuminators and lighting solutions, has recently launched an all-new catalog of configurable LED products. Built by CADENAS PARTsolutions, the new tool makes it faster and easier for manufacturing engineers to source the correct lighting product for their application.

Key Points: 
  • CINCINNATI and BRISTOL, Pa., Aug. 11, 2022 /PRNewswire/ -- Metaphase Technologies , a nearly 30-year-old, Pennsylvania-based manufacturer of LED illuminators and lighting solutions, has recently launched an all-new catalog of configurable LED products.
  • Built by CADENAS PARTsolutions, the new tool makes it faster and easier for manufacturing engineers to source the correct lighting product for their application.
  • Metaphase Technologies designs and manufactures LED illuminators for machine vision, military, and specialty lighting applications.
  • The Metaphase Technologies online catalog of LED illuminators will also deliver PDF datasheets, complete with configured product details and an interactive 3D preview.

KromaTiD Launches dGH™ Cell Prep Kit

Retrieved on: 
Tuesday, July 19, 2022
IPSC, Solution, Cell, Technology, DNA, Catalog, DGH, Metaphase, Medication, Pinpoint, Gene, SCREEN, Single-cell analysis, Microscope, Research

LONGMONT, Colo., July 19, 2022 /PRNewswire/ -- KromaTiD, a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch of their dGH Cell Prep Kit for use in their dGH in-Site and dGH SCREEN assays.

Key Points: 
  • LONGMONT, Colo., July 19, 2022 /PRNewswire/ -- KromaTiD, a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch of their dGH Cell Prep Kit for use in their dGH in-Site and dGH SCREEN assays.
  • KromaTiD has been providing high-resolution assays with superior detection, and robust data for large Pharmaceutical and Gene and Cell therapy companies for over 13 years.
  • KromaTiD's VP of Research and Development Erin Cross says, "The dGH Cell Prep Kit contains a media additive which incorporates into DNA during replication and allows the daughter stand to be stripped from metaphase chromosomes.
  • The dGH Cell Prep Kit has a unique method which enables high resolution, direct measurement of inversions, translocations, a whole genome structural variant analysis, selecting structurally pure IPSC clone and other structural variations.

KromaTiD Announces the Launch of Cell Culture Services

Retrieved on: 
Tuesday, February 1, 2022
Metaphase, DNA, Cell, DGH, Fine chemical

LONGMONT, Colo., Feb. 1, 2022 /PRNewswire/ -- Building on over ten years of experience in the cell culture and isolation of cell products, KromaTiD is excited to announce the launch of a comprehensive suite of Cell and Blood Culture growth, isolation, processing, and quality control services.

Key Points: 
  • LONGMONT, Colo., Feb. 1, 2022 /PRNewswire/ -- Building on over ten years of experience in the cell culture and isolation of cell products, KromaTiD is excited to announce the launch of a comprehensive suite of Cell and Blood Culture growth, isolation, processing, and quality control services.
  • Focused on the cell types most important for gene and cell therapy and oncology applications, KromaTiD will grow your IPSCs, T-Cells, adherent/non-adherent cell lines or blood samples at scale, qualify your cells with a wide array of cellular assays and then isolate and ship your standard cell products such as DNA, T-Cells, or metaphase chromosomes for your downstream use.
  • Beyond their growing list of standard cell services, if you have proprietary or engineered cell lines or very specific testing requirements KromaTiD will tailor a cell service to meet your specific requirements.
  • Erin Cross, KromaTiD's Director of Whole Genome Analysis had this to say on our cell services "Cell services have always been an integral part of the single-cell whole-genome analysis KromaTiD is known for".We optimized these processes for our large pharma and gene therapy customers, and we are delighted to now offer our industry-leading expertise in cell culture, cell products, and single-cell assays to the world."

Global Fluorescent in Situ Hybridization Probe Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, October 29, 2021
Biotechnology, Genetics, Health, Chromosome, Research, Biotechnology, Diagnosis, Technology, Cancer, Industry, Metaphase, FISH, Interphase, Lists of diseases, Growth, COVID-19, R, In situ hybridization, IVD, Prevalence, Non-functional testing, Medical imaging, Microscope, Potash

Fluorescent in Situ Hybridization (FISH) Probe refers to a sub-atomic cytogenetic technique that uses fluorescent probes to visualize genetic materials.

Key Points: 
  • Fluorescent in Situ Hybridization (FISH) Probe refers to a sub-atomic cytogenetic technique that uses fluorescent probes to visualize genetic materials.
  • How has the global fluorescent in situ hybridization (FISH) probe market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global fluorescent in situ hybridization (FISH) probe market?
  • What is the structure of the global fluorescent in situ hybridization (FISH) probe market and who are the key players?

Global Cytogenetics Technologies, Companies and Markets to 2027

Retrieved on: 
Wednesday, August 22, 2018
Biology, Cytogenetics, Laboratory techniques, Molecular biology, Genetics, Comparative genomic hybridization, Fluorescence in situ hybridization, Nucleic acid hybridization, CGH, In situ hybridization, Molecular Cytogenetics, Metaphase

The "Cytogenetics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cytogenetics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • Historical landmarks in the evolution of cytogenetics are reviewed since the first images of chromosomes were made in 1879.
  • The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH.
  • The chapter on markets provides a global perspective of the cytogenetics business in the major markets: US, Western Europe (including France, Germany, Italy, Spain, and the UK), and Japan.